Antiretroviral Formulations
A comparative list of antiretroviral drug formulations by class (NNRTIs, NRTIs, protease inhibitors, entry/fusion inhibitors, integrase inhibitors, PK enhancer, fixed-dose combination) for HIV-1 infection.
Infectious Disease
Antiretroviral Contraindications and Drug Interactions
A list of contraindications and drug interactions for HIV medications.
FDA, FTC Crack Down on Fraudulent COVID-19 “Treatments”
Warning letters issued by the FDA and the Federal Trade Commission (FTC) have been sent to several companies selling fraudulent products claiming to treat or prevent coronavirus 2019 (COVID-19).
Influenza Vaccine Effectiveness for 2019-2020 Season Assessed
The CDC continues to recommend influenza vaccination as the best method of protection while the viruses are circulating in the community.
First Ebola Vaccine Receives FDA Approval
The FDA has approved Ervebo (Ebola Zaire vaccine, live) for the prevention of disease caused by Zaire ebolavirus in individuals ≥18 years of age.
Hepatitis C Virus Treatment Guidelines
Evidence-based treatment guidelines for HCV infection from the expert panel of the AASLD and IDSA.
Antibiotic Formulations
Antibiotic formulation (tablets, capsules, liquids, inhalations or injection) chart.
Community Acquired Pneumonia Guidelines
Diagnose, treat, and prevent community acquired pneumonia using key recommendations from the IDSA/ATS CAP guidelines.
Recommended Indications for PrEP Use
Indications for PrEp use in men who have sex with men (MSM), heterosexually active men and women, and injection drug users.
